LENZ · LENZ Therapeutics, Inc.
$4.67
+0.08 (+1.74%)
At close · Aug 25
Market Cap
$146.06M
Shares
31.42M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-08-11 | 2026-06-30 | |
| 8-K | 2026-08-11 | — | |
| 8-K | 2026-07-02 | 2026-06-30 | |
| 8-K | 2026-06-12 | — | |
| 8-K | 2026-05-11 | — | |
| 10-Q | 2026-05-11 | 2026-03-31 | |
| DEF 14A | 2026-04-28 | 2026-06-12 | |
| 10-K | 2026-03-24 | 2025-12-31 | |
| 8-K | 2026-03-24 | — | |
| 8-K | 2026-01-07 | — | |
| 8-K | 2025-12-12 | — | |
| 8-K | 2025-11-05 | — | |
| 10-Q | 2025-11-05 | 2025-09-30 | |
| 8-K | 2025-10-08 | — | |
| 8-K | 2025-09-30 | — | |
| 8-K | 2025-07-31 | — | |
| 8-K | 2025-07-30 | — | |
| 10-Q | 2025-07-30 | 2025-06-30 | |
| 8-K | 2025-06-10 | — | |
| 10-Q | 2025-05-07 | 2025-03-31 | |
| 8-K | 2025-05-07 | — | |
| DEF 14A | 2025-04-28 | 2025-06-10 | |
| 8-K | 2025-04-15 | — | |
| 8-K | 2025-04-04 | — | |
| 8-K | 2025-03-19 | — | |
| 10-K | 2025-03-19 | 2024-12-31 | |
| 10-Q | 2024-11-06 | 2024-09-30 | |
| 8-K | 2024-11-06 | — | |
| 8-K | 2024-10-28 | 2024-10-27 | |
| 8-K | 2024-08-14 | — | |
| 10-Q | 2024-08-14 | 2024-06-30 | |
| 8-K | 2024-08-12 | — | |
| 8-K | 2024-07-15 | 2024-07-14 | |
| 10-Q | 2024-05-08 | 2024-03-31 | |
| 8-K | 2024-05-08 | — | |
| 8-K | 2024-04-03 | — | |
| 8-K | 2024-03-22 | 2024-03-21 | |
| 8-K | 2024-03-19 | — | |
| 8-K | 2024-03-14 | — | |
| 8-K | 2024-03-08 | — | |
| 8-K | 2024-03-05 | — | |
| 10-K | 2024-02-27 | 2023-12-31 | |
| 8-K | 2023-12-26 | 2023-12-21 | |
| 8-K | 2023-11-15 | 2023-11-14 | |
| 10-Q | 2023-11-13 | 2023-09-30 | |
| 8-K | 2023-10-30 | 2023-10-26 | |
| 8-K/A | 2023-09-13 | 2023-08-18 | |
| 8-K | 2023-08-23 | 2023-08-18 | |
| 10-Q | 2023-08-14 | 2023-06-30 | |
| 8-K | 2023-08-02 | 2023-07-28 |
Showing 1–50 of 85 filings
Key facts
CIK
1815776
CUSIP
52635N103
13F (30d)
127 filings
127 filers
Visit website
Investor relations